BRIEF published on 11/22/2024 at 14:51, 18 hours 12 minutes ago Vanguard Group Discloses Position in International Paper Company Form 8.3 Takeover Code Vanguard Group Stock Disclosure International Paper
BRIEF published on 11/22/2024 at 14:50, 18 hours 13 minutes ago The Vanguard Group Discloses Significant Interest in Centamin plc Takeover Code Securities Disclosure Vanguard Group Mining Sector Centamin Plc
BRIEF published on 11/22/2024 at 14:49, 18 hours 14 minutes ago The Vanguard Group Discloses Position in AngloGold Ashanti Takeover Code Securities Disclosure Vanguard Group AngloGold Ashanti Share Dealings
BRIEF published on 11/22/2024 at 14:47, 18 hours 16 minutes ago Vanguard Discloses Shares in Hargreaves Lansdown Form 8.3 Vanguard Group Shareholding Disclosure Investment Transactions Hargreaves Lansdown
PRESS RELEASE published on 11/22/2024 at 14:46, 18 hours 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses 11.83% interest in International Paper Company. Form 8.3 filing made on 22-Nov-2024 Form 8.3 Vanguard Group Interest Disclosure Stock Holdings International Paper Company
PRESS RELEASE published on 11/22/2024 at 14:45, 18 hours 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc The Vanguard Group, Inc. discloses 2.20% ownership in Centamin plc as of 21 Nov 2024 Vanguard Group Ownership Disclosure Financial Disclosure Stock Market Centamin Plc
BRIEF published on 11/22/2024 at 14:45, 18 hours 18 minutes ago The Vanguard Group Discloses Position in Smith (DS) plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Smith (DS) Plc
PRESS RELEASE published on 11/22/2024 at 14:44, 18 hours 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses a 4.41% stake in AngloGold Ashanti plc. Also making disclosures related to Centamin plc. Details as per Form 8.3 Form 8.3 Disclosure Vanguard Group AngloGold Ashanti Centamin Plc
PRESS RELEASE published on 11/22/2024 at 14:42, 18 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses their 3.96% ownership of Hargreaves Lansdown plc's 0.4p ordinary shares in a Form 8.3 filing as of 21 Nov 2024 Form 8.3 Vanguard Group Ownership Disclosure Financial Securities Hargreaves Lansdown Plc
PRESS RELEASE published on 11/22/2024 at 14:40, 18 hours 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.93% ownership in Smith (DS) plc. Additional disclosures made regarding International Paper Company Disclosure The Vanguard Group Smith (DS) Plc Ownership International Paper Company
Published on 11/22/2024 at 23:55, 9 hours 9 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 34 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 9 hours 59 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 34 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 10 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 8 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 4 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
